Natural Products and lncRNAs in Renal Cell Carcinoma: Emerging Therapeutic Approaches

Ahmed S Doghish1,2, Mai A Abd-Elmawla3, Nora M Aborehab4

  • 1Department of Biochemistry, Faculty of Pharmacy, Badr University in Cairo (BUC), Cairo, Egypt.

Insights

Long noncoding RNAs (lncRNAs) are key in renal cell carcinoma (RCC) progression and treatment resistance. Natural compounds show promise for targeting lncRNAs in novel RCC therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Renal cell carcinoma (RCC) is a prevalent cancer with poor outcomes, often resistant to conventional treatments.
  • Long noncoding RNAs (lncRNAs) are implicated in RCC pathogenesis, influencing key processes like proliferation, metastasis, and therapeutic resistance.
  • Existing therapies for advanced RCC are limited, necessitating exploration of novel therapeutic targets and strategies.

Purpose of the Study:

  • To review the biogenic pathways and functions of lncRNAs in renal cell carcinoma (RCC).
  • To elucidate the role of lncRNAs in RCC pathophysiology, posttranscriptional regulation, and therapeutic resistance.
  • To explore the potential of natural compounds in targeting lncRNA-mediated pathways for novel RCC treatment strategies.

Main Methods:

  • Literature review of studies on lncRNAs in renal cell carcinoma (RCC).
  • Analysis of lncRNA involvement in critical cellular pathways (EMT, proliferation, apoptosis, angiogenesis, metastasis).
  • Examination of lncRNA roles in chemoresistance and radioresistance in RCC.
  • Investigation into natural compounds (curcumin, quercetin, resveratrol) targeting lncRNA pathways.

Main Results:

  • lncRNAs are crucial molecular mediators in RCC, regulating key oncogenic pathways.
  • lncRNAs significantly contribute to chemoresistance and radioresistance in renal cell carcinoma (RCC).
  • Natural compounds demonstrate potential for targeting lncRNA-mediated pathways in RCC.

Conclusions:

  • lncRNAs represent significant molecular players in renal cell carcinoma (RCC) development and progression.
  • Targeting lncRNAs with natural compounds offers a promising avenue for developing novel and personalized RCC therapies.
  • Further research into lncRNA-targeted therapies could improve treatment outcomes for renal cell carcinoma (RCC) patients.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.8K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
13.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
Types of RNA01:20

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
16.2K